Logo
I

Invenra

56 employees

Invenra offers flexible partnering options to meet diverse antibody discovery needs, from rapid, focused bispecific antibody discovery to comprehensive, collaborative development partnerships. Our new rapid bispecific discovery service, powered by the B-Body® Bispecific Platform, identifies bispecific lead panels within four months through functional screening of over 250 bispecific combinations, using mAbs derived from 90 parallel discovery screens. For those seeking a strategic, partnered approach, Invenra provides tailored support across all stages of discovery, from custom antigen design and assay development to in-depth biological analysis. This dual offering allows us to address a broad spectrum of objectives, from expedited project timelines for focused discovery services to fully integrated solutions for collaborative development partnerships.

Investor insights

Funding rounds participated in

$7M sweet spot round size

Investor type

Privately Held

Basic info

Industry

Biotechnology Research

Sectors

Biotechnology Research

Date founded

2011

Funding rounds raised

Total raised

$7M

from 1 investors over 1 rounds

I

Invenra raised $7M on November 17, 2018

Investors: Venture Investors

FAQ